Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT02787304 · TERMINATED
Trial details
- NCT number
- NCT02787304
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-24
- Primary completion
- 2018-07-27
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.